Sigyn Therapeutics Announces Corporate Update Webinar
b'SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions, announced today that its Chairman and CEO, Jim Joyce will give a \xe2\x80\x9clive\xe2\x80\x9d corporate update webinar this Friday, May 21st\xc2\xa0at 11am eastern time.\nMr.
- b'SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions, announced today that its Chairman and CEO, Jim Joyce will give a \xe2\x80\x9clive\xe2\x80\x9d corporate update webinar this Friday, May 21st\xc2\xa0at 11am eastern time.\nMr.
- Joyce will review a series of recent milestones that support the advancement of Sigyn Therapy\xe2\x84\xa2, a novel blood purification technology designed to treat sepsis and other life-threatening conditions precipitated by cytokine storm syndrome.\xc2\xa0\xc2\xa0Mr.
- Sigyn anticipates that subsequent events and developments may cause its views to change.
- However, while it may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.